Overexpression and activation of AIB1 is associated with endocrine resistance in human breast cancer [20], [21], [22] and has been shown to be rate-limiting for estrogen-induced growth of breast cancer cells [23], [24]. This evidence concerns the gene NCOA3 and breast cancer.